Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Study With OXN to Evaluate the Patient Preference for Pain Treatment With Respect to Quality of Life After WHO Stap I or Step II Analgesics for Patients With Moderate to Severe Non-malignant Pain

NCT01167699 is registered in ClinicalTrials.gov with Mundipharma Pharmaceuticals B.V. as lead sponsor.

NCT NCT01167699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01167699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Study With OXN to Evaluate the Patient Preference for Pain Treatment With Respect to Quality of Life After WHO Stap I or Step II Analgesics for Patients With Moderate to Severe Non-malignant Pain
Lead sponsor
Mundipharma Pharmaceuticals B.V.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2009
Completion date
April 30, 2011
Enrollment
174 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain